Home » Topics » Regulatory

Regulatory
RSS

FDA grants marketing approval for Shire's VPRIV for type 1 GD

March 1, 2010

FDA approves Novartis' Menveo vaccine for meningococcal disease

Feb. 22, 2010

FDA grants approval to Daiichi's hypertension treatment Benicar in pediatric patients

Feb. 12, 2010

FDA approves Xiaflex for debilitating hand disease

Feb. 4, 2010

FDA grants marketing approval to Acorda's Ampyra to improve walking in MS patients

Jan. 25, 2010

Daiichi granted Japanese approval to manufacture and market Rezaltas for hypertension

Jan. 21, 2010

Shionogi receives marketing approval for peramivir in Japan

Jan. 15, 2010

BioMarin's amifampridine phosphate approved in the EU for LEMS

Jan. 7, 2010

Novartis' Onbrez Breezhaler approved in E.U. for patients with COPD

Dec. 4, 2009

Kalbitor approved in U.S. for hereditary angioedema

Dec. 3, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...